In: Biology
Speculate on the effects of a drug that competitively blocks ATP binding site in the RSC complex in yeast based on nucleosomal remodeling.
Drug that competitively block the ATP binding site in the RSC complex will lead to decreased functioning of polymerase and less or decreased expression of gene.
Explanation
histone acetyltransferases (HATs) work in coordination with ATP-dependent chromatin remodeling enzymes which affect promoter-dependent transcription initiation of gene thus regulating gene expression.
RSC is a bromodomain-containing ATPase. During transcription in yeast RNA polymerase II (Pol II) arrests at positioned mononucleosome. RSC use energy release by ATP hydrolysis, stimulates passage of Pol II through these sites thus facilitate expression of gene.
If we use drug that competitively block ATP binding site thus on RSC protein. Than RSC will not able to function with out hydrolysis of ATP and will not be able to stimulate polymerase thus not able to stimulate expression of gene.